NovoCure (NVCR) Inventory Average (2015 - 2026)

NovoCure's Inventory Average history runs 12 years deep, the most recent figure standing at $42.3 million for Q1 2026.

• In Q1 2026, Inventory Average rose 13.43% year-over-year to $42.3 million; the TTM figure through Mar 2026 stood at $42.3 million (up 13.43% YoY), while the FY2025 annual figure was $38.1 million, up 4.04% from the prior year.
• Inventory Average came in at $42.3 million for Q1 2026 at NovoCure, up from $40.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $42.3 million in Q1 2026 to a low of $26.8 million in Q1 2022.
• A 5-year average of $35.6 million and a median of $37.3 million in 2025 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average jumped 33.45% in 2023 and declined 7.44% in 2025, its largest moves.
• NovoCure's Inventory Average stood at $28.1 million in 2022, then surged by 33.45% to $37.5 million in 2023, then slipped by 1.04% to $37.1 million in 2024, then climbed by 8.13% to $40.1 million in 2025, then grew by 5.43% to $42.3 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $42.3 million, $40.1 million, and $39.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison